SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FreedomForAll who wrote (1747)2/15/1997 12:17:00 PM
From: John H. Farro   of 4342
 
David, you wrote:

"I agree with your take on the profit calculation. If the figures
announced are honest (securities laws and accounting standards are pretty exact on how these calculations can be done) then they are talking bottom line."

The figures may be honest, but the interpretations may differ. I know Christine did a great job reporting, but let's remember that this is a second hand report. I would have to have been at the presentation to know exactly how they phrased their statements and the context in which they used the word "profit" Of course

profit = income - expenses,

The key question is, do the expenses include just the direct expenses involved in producing AndroVir or do they also include the overhead expenses of ongoing research, etc. It is difficult to tell from a second hand report, excellent though it is. I hope that you and Richard are right and that the company will have a large net profit after AndroVir and AndroCar has been on the market for a year. I could very easily be wrong in my interpretation. But I think it is difficult to decide the truth of this matter based on a second hand report.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext